Skip to main content
. 2020 Mar 26;34(5):545–553. doi: 10.1007/s40263-020-00720-w

Fig. 1.

Fig. 1

Time to seizure recurrence after index seizure with or without application of intranasal midazolam for an observation period of 24 h. Results from a Cox-regression approach are shown using clusters for individual patients (p < 0.001; hazard ratio 0.61; 95% confidence interval 0.49–0.76). in-MDZ intranasal midazolam